These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 21237297)

  • 1. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic profiling of ovarian cancer models using TMT-LC-MS/MS.
    Sinclair J; Timms JF
    Methods Mol Biol; 2013; 1049():271-84. PubMed ID: 23913223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
    Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
    Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2D-DIGE analysis of ovarian cancer cell responses to cytotoxic gold compounds.
    Guidi F; Puglia M; Gabbiani C; Landini I; Gamberi T; Fregona D; Cinellu MA; Nobili S; Mini E; Bini L; Modesti PA; Modesti A; Messori L
    Mol Biosyst; 2012 Apr; 8(4):985-93. PubMed ID: 22134777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies.
    Timms JF; Arslan-Low E; Kabir M; Worthington J; Camuzeaux S; Sinclair J; Szaub J; Afrough B; Podust VN; Fourkala EO; Cubizolles M; Kronenberg F; Fung ET; Gentry-Maharaj A; Menon U; Jacobs I
    Proteomics Clin Appl; 2014 Dec; 8(11-12):982-93. PubMed ID: 25290619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.
    Lawrenson K; Mhawech-Fauceglia P; Worthington J; Spindler TJ; O'Brien D; Lee JM; Spain G; Sharifian M; Wang G; Darcy KM; Pejovic T; Sowter H; Timms JF; Gayther SA
    Int J Cancer; 2015 Oct; 137(8):1806-17. PubMed ID: 25204737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary proteome profiling using 2D-DIGE and LC-MS/MS.
    Weeks ME
    Methods Mol Biol; 2010; 658():293-309. PubMed ID: 20839112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2D gel electrophoresis and mass spectrometry identification and analysis of proteins.
    Meleady P
    Methods Mol Biol; 2011; 784():123-37. PubMed ID: 21898217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional Gel Electrophoresis Coupled with Mass Spectrometry Methods for an Analysis of Human Pituitary Adenoma Tissue Proteome.
    Zhan X; Huang Y; Long Y
    J Vis Exp; 2018 Apr; (134):. PubMed ID: 29658936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.
    Huang H; Li Y; Liu J; Zheng M; Feng Y; Hu K; Huang Y; Huang Q
    PLoS One; 2012; 7(12):e51256. PubMed ID: 23251472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of human hepatocellular carcinoma-related biomarkers by two-dimensional difference gel electrophoresis and mass spectrometry.
    Lee IN; Chen CH; Sheu JC; Lee HS; Huang GT; Yu CY; Lu FJ; Chow LP
    J Proteome Res; 2005; 4(6):2062-9. PubMed ID: 16335951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of ovarian cancer-associated proteins in symptomatic women: A novel method for semi-quantitative plasma proteomics.
    Shield-Artin KL; Bailey MJ; Oliva K; Liovic AK; Barker G; Dellios NL; Reisman S; Ayhan M; Rice GE
    Proteomics Clin Appl; 2012 Apr; 6(3-4):170-81. PubMed ID: 22532453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Discrimination and clinical value of plasma metabolomic profiles in multidrug resistant epithelial ovarian cancer].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):896-902. PubMed ID: 29262505
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome profiling of Epstein-Barr virus infected nasopharyngeal carcinoma cell line: identification of potential biomarkers by comparative iTRAQ-coupled 2D LC/MS-MS analysis.
    Feng X; Zhang J; Chen WN; Ching CB
    J Proteomics; 2011 Apr; 74(4):567-76. PubMed ID: 21296196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
    Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
    Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.